All In Biotech

Free tool

FAERS Monitor: Veltassa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205739 or its brand name (Veltassa, Patiromer Sorbitex Calcium). Reports on generic versions are filed under their own applications.

Reports

13,806

Serious

6,761

49% of reports

Hospitalization

3,806

Death reported

2,126

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • constipation2,146
  • death1,832
  • diarrhoea1,296
  • hospitalisation980
  • off label use941
  • blood potassium increased802
  • nausea713
  • drug dose omission672
  • malaise584
  • abdominal discomfort541
  • inappropriate schedule of drug administration461
  • vomiting450
  • abdominal pain upper427
  • no adverse event377
  • dyspnoea374

Reports by year received

View as table
YearReports
20163,462
20174,594
20181,774
20191,327
2020896
2021569
2022313
2023192
2024191
2025318
2026170

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,353 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood potassium increasedSignal80279.173.958,793
constipationSignal2,14615.114.528,320
inappropriate schedule of drug administrationSignal4619.99.13,682
hospitalisationSignal9809.89.27,716
drug dose omissionSignal6726.25.82,946
abdominal discomfortSignal5414.94.51,697
deathSignal1,8323.23.12,957
no adverse eventSignal3773.22.9563
abdominal pain upperSignal4273.22.9635
diarrhoeaSignal1,2963.12.91,852
malaiseSignal5842.01.9310
off label use9411.61.5243
vomiting4501.51.366
nausea7131.41.375
dyspnoea3741.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.